Bvf Inc Mirum Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 2,796,513 shares of MIRM stock, worth $147 Million. This represents 4.33% of its overall portfolio holdings.
Number of Shares
2,796,513
Previous 3,075,907
9.08%
Holding current value
$147 Million
Previous $120 Million
3.61%
% of portfolio
4.33%
Previous 3.81%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$345 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$240 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$170 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$137 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$127 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.93B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...